Innovata claims US laparoscopic first for anti-adhesion fluid
This article was originally published in Clinica
Scoring a US first, UK firm Innovata has gained FDA approval to sell a product for reducing the formation of painful adhesions in women undergoing gynaecological laparoscopic procedures.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.